Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Mol Cell Biol ; 17(6): 3305-14, 1997 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-9154829

RESUMO

The centromere enhancer is a functionally important DNA region within the Schizosaccharomyces pombe centromeric K-type repeat. We have previously shown that addition of the enhancer and cen2 centromeric central core to a circular minichromosome is sufficient to impart appreciable centromere function. A more detailed analysis of the enhancer shows that it is dispensable for centromere function in a cen1-derived minichromosome containing the central core and the remainder of the K-type repeat, indicating that the critical centromeric K-type repeat, like the central core, is characterized by functional redundancy. The centromeric enhancer is required, however, for a central core-carrying minichromosome to exhibit immediate centromere activity when the circular DNA is introduced via transformation into S. pombe. This immediate activation is probably a consequence of a centromere-targeted epigenetic system that governs the chromatin architecture of the region. Moreover, our studies show that two entirely different DNA sequences, consisting of elements derived from two native centromeres, can display centromere function. An S. pombe CENP-B-like protein, Abp1p/Cbp1p, which is required for proper chromosome segregation in vivo, binds in vitro to sites within and adjacent to the modular centromere enhancer, as well as within the centromeric central cores. These results provide direct evidence in fission yeast of a model, similar to one proposed for mammalian systems, whereby no specific sequence is necessary for centromere function but certain classes of sequences are competent to build the appropriate chromatin foundation upon which the centromere/kinetochore can be formed and activated.


Assuntos
Centrômero/genética , Cromatina/genética , DNA Fúngico/genética , Elementos Facilitadores Genéticos , Proteínas Nucleares , Proteínas de Saccharomyces cerevisiae , Schizosaccharomyces/genética , Sítios de Ligação , DNA Circular/metabolismo , DNA Fúngico/química , DNA Fúngico/metabolismo , Proteínas de Ligação a DNA/metabolismo , Desoxirribonucleases de Sítio Específico do Tipo II/metabolismo , Proteínas Fúngicas/metabolismo , Cinetocoros , Ligação Proteica , Sequências Repetitivas de Ácido Nucleico , Mapeamento por Restrição
2.
Mol Biol Cell ; 5(7): 747-61, 1994 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-7812044

RESUMO

The DNA requirements for centromere function in fission yeast have been investigated using a minichromosome assay system. Critical elements of Schizosaccharomyces pombe centromeric DNA are portions of the centromeric central core and sequences within a 2.1-kilobase segment found on all three chromosomes as part of the K-type (K/K"/dg) centromeric repeat. The S. pombe centromeric central core contains DNA sequences that appear functionally redundant, and the inverted repeat motif that flanks the central core in all native fission yeast centromeres is not essential for centromere function in circular minichromosomes. Tandem copies of centromeric repeat K", in conjunction with the central core, exert an additive effect on centromere function, increasing minichromosome mitotic stability with each additional copy. Centromeric repeats B and L, however, and parts of the central core and its core-associated repeat are dispensable and cannot substitute for K-type sequences. Several specific protein binding sites have been identified within the centromeric K-type repeat, consistent with a recently proposed model for centromere/kinetochore function in S. pombe.


Assuntos
Autoantígenos , Centrômero , Cromossomos Fúngicos/ultraestrutura , DNA Fúngico/genética , Schizosaccharomyces/genética , Sequência de Bases , Sítios de Ligação , Proteína B de Centrômero , Proteínas Cromossômicas não Histona/metabolismo , DNA Circular/genética , DNA Recombinante , Proteínas de Ligação a DNA/metabolismo , Cinetocoros/ultraestrutura , Dados de Sequência Molecular , Plasmídeos , Reação em Cadeia da Polimerase , Sequências Repetitivas de Ácido Nucleico
3.
Cancer Res ; 60(18): 5045-51, 2000 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-11016627

RESUMO

Vinflunine is a novel Vinca alkaloid presently in Phase I clinical trials. In preclinical studies, it exhibited superior antitumor activity to that of other Vinca alkaloids, including vinorelbine from which it was synthetically derived. Vinca alkaloids appear to inhibit cell proliferation by affecting the dynamics of spindle microtubules. Here we have analyzed the effects of vinflunine and vinorelbine on microtubule dynamic instability and treadmilling and found that these newer drugs exert effects on microtubule dynamics that differ significantly from those of the classic Vinca alkaloid, vinblastine. The major effects of vinflunine and vinorelbine on dynamic instability were a slowing of the microtubule growth rate, an increase in growth duration, and a reduction in shortening duration. In marked contrast to the action of vinblastine, they neither reduced the rate of shortening nor increased the percentage of time the microtubules spent in an attenuated state, neither growing nor shortening detectably. In addition, vinflunine and vinorelbine suppressed treadmilling, but less strongly than vinblastine. The diverse actions of these drugs on microtubules are likely to produce different effects on mitotic spindle function, leading to different effects on cell cycle progression and cell killing. Nontumor cells with normal checkpoint proteins may tolerate the relatively less powerful inhibitory effects of vinflunine and vinorelbine on microtubule dynamics better than the more powerful effects of vinblastine. Thus the unique constellation of effects of vinflunine and vinorelbine on dynamic instability and treadmilling may contribute to their superior antitumor efficacies.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Microtúbulos/efeitos dos fármacos , Vimblastina/análogos & derivados , Vimblastina/farmacologia , Animais , Microtúbulos/metabolismo , Ouriços-do-Mar , Tubulina (Proteína)/metabolismo , Vinorelbina
4.
Mol Pharmacol ; 60(1): 225-32, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11408618

RESUMO

The two second-generation Vinca alkaloids, vinorelbine and vinflunine, affect microtubule dynamics very differently from vinblastine, a first generation Vinca alkaloid. For example, vinblastine strongly suppresses the rate and extent of microtubule shortening in vitro, whereas vinorelbine and vinflunine suppress the rate and extent of microtubule growing events. We asked whether these differences result in differences in mitotic spindle organization that might be responsible for the superior antitumor activities of the two second-generation Vinca alkaloids. IC(50) values for inhibition of HeLa cell proliferation for vinflunine, vinorelbine, and vinblastine were 18, 1.25, and 0.45 nM, respectively, similar to the concentrations that induced mitotic block at the metaphase/anaphase transition (38, 3.8, and 1.1 nM, respectively), indicating that mitotic block is a major contributor to antiproliferative action for all three drugs. Mitotically blocked cells exhibited aberrant spindles, consistent with induction of block by suppression of microtubule dynamics. Despite differences in their actions on individual dynamic instability parameters, morphologically detectable differences in spindle effects among the three drugs were minimal, indicating that overall suppression of dynamics may be more important in blocking mitosis than specific effects on growth or shortening. We also found that the peak intracellular drug concentration at the mitotic IC(50) value was highest for vinflunine (4.2 +/- 0.2 microM), intermediate for vinorelbine (1.3 +/- 0.1 microM), and more than 10-fold lower for vinblastine (130 +/- 7 nM), suggesting that intracellular binding reservoir(s) may be partially responsible for vinflunine's high efficacy and minimal side effects.


Assuntos
Antineoplásicos Fitogênicos/farmacologia , Mitose/efeitos dos fármacos , Fuso Acromático/efeitos dos fármacos , Vimblastina/análogos & derivados , Vimblastina/farmacologia , Divisão Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Células HeLa , Humanos , Microtúbulos/efeitos dos fármacos , Microtúbulos/fisiologia , Fuso Acromático/fisiologia , Alcaloides de Vinca/farmacologia , Vinorelbina
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa